Hypertension (HTN)
66
23
26
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
3.0%
2 terminated out of 66 trials
85.7%
-0.8% vs benchmark
5%
3 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (66)
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Mortality Outcome of Controlled Blood Pressure Participants
Syntrillo Telehealth Stroke Risk Reduction Study
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Mobile Health Program for Post-Preeclampsia Hypertension
Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)
Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Navigating Hypertension and Food Insecurity
Impact of Online Medical Misinformation
Project HOPE (Hypertension Outreach Through Partnership and Engagement)
Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
IMPACT-HTN Study of Patients With Hypertension
University of Georgia Mind Your Heart Pilot Study
Usefulness of the VExUS Protocol for Dry-Weight Adjustment in Hemodialysis Patients: The Multicenter VExHD Study
To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years
RUSH Food is Medicine Veggie Rx - GusNIP Produce Prescription
Dual-Language B-MORE for Hypertension
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
A Phase Ⅰ b Clinical Study of ART101 Injection